SCI PHARMTECH, INC.
旭富製藥科技股份有限公司
Leave your email for change alerts (optional)
1987Founded
NT$1.2BPaid-in capital
3Plants
6Certifications
2Patents
NT$1–5BRevenue band
- Unified Business No.
- 22662545
- Industry
- Other Chemical Products (2,066)
- Main products
- Other chemical products n.e.c. (627)
- Location
- No. 61, Ln. 309, Haihu N. Rd., 13th Neighborhood, Binhai Vil., Luzhu Dist., Taoyuan City 338025, Taiwan (R.O.C.)
Taoyuan City (10,976) · Luzhu Dist. (1,965) - Listing
- Listed (TWSE) (1,087) 4119
- Registration status
- Approved / Active
- Organisation type
- Company Limited by Shares
- Founded
- 1987-09-18
- Paid-in capital
- NT$ 1,195,086,340
- Representative
- Weng Wei-chun
- Phone
- 03-3543133
- Website
- http://www.sci-pharmtech.com.tw
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$1–5B
- Ownership
- Group subsidiary / corporate-held · San Shang Tou Tzu Holdings Co., Ltd.
- North American market
- FDA drug establishment registration
- Representative tenure
- In office since 2014-03 (12 yrs); last handover 2014-03
- Growth & profitability
- Revenue 2026-09 YoY +33.1%, year-to-date +16.6%
Gross margin 21.2%, operating margin 6.5%, net margin 1.1% (2026-Q2 YTD) - Compliance record
- Environmental penalties: 1 case(s) in 5 years, latest 2022-10-07, fines NT$ 108,000 (water pollution)
Occupational safety penalties: 3 case(s) in 5 years, latest 2025-08-22, fines NT$ 260,000 (Art. 177; Art. 11; Art. 184) — matched by company name
Plants 3
- Taoyuan Plant 2 · No. 61, Ln. 309, Haihu N. Rd., Luzhu Dist., Taoyuan City In production
- Taoyuan Plant · No. 61, Ln. 309, Haihu N. Rd., Luzhu Dist., Taoyuan City In production
- Guanyin Plant · No. 5, Gongye 5th Rd., Guanyin Dist., Taoyuan City In production
Certifications 6
- Medical device license (Class I) (1,430)Official registry Valid until 2016-09-06 · Taiwan Food and Drug Administration (TFDA)
- GMP (261)Self-reported
- ISO 14001 (1,159)Self-reported
- ISO 9001 (4,293)Self-reported
- OHSAS 18001 (157)Self-reported
- PIC/S GMP (46)Self-reported
Processes & materials 2
- Pharmaceuticals (159) · Company nameSelf-reported
- Cleanroom production (392) · Assembly & inspectionSelf-reported
Patents 2
- 2024 Purification method of terpenoid amino alcohol derivative
- 2021 Method for preparing cannabidiol
North American market evidence 1
- FDA drug establishment registration 3004065859 12/31/2026
ANALYSIS; API MANUFACTURE
Similar companies 10
- U-LIANG PHARMACEUTICAL CO., LTD. · Hsinchu County NT$100–500M estimated
Shared: Pharmaceuticals, Medical device license (Class I), Human pharmaceutical manufacturing, Veterinary pharmaceutical manufacturing - HSIN WAN JEN CHEMICAL & PHARMACEUTICAL CO., LTD. · Taichung City < NT$20M estimated
Shared: Pharmaceuticals, Human pharmaceutical manufacturing - PAOLYTA CO., LTD. · Hsinchu County NT$1–5B estimated
Shared: Medical device license (Class I), GMP, PIC/S GMP, Human pharmaceutical manufacturing - BIOCROWN BIOTECHNOLOGY CO., LTD. · Taichung City NT$20–100M estimated
Shared: Cleanroom production, GMP, PIC/S GMP - KOJAR PHARMACEUTICAL INDUSTRIAL CO., LTD. · Taichung City NT$20–100M estimated
Shared: Pharmaceuticals, Cleanroom production, GMP, PIC/S GMP - JORMED BIOTECH CORPORATION · Taoyuan City NT$20–100M estimated
Shared: Cleanroom production, GMP, Western pharmaceutical retail - MEIDER PHARMACEUTICAL CO., LTD. · Taoyuan City < NT$20M estimated
Shared: Pharmaceuticals, Human pharmaceutical manufacturing - WINSTON MEDICAL SUPPLY CO., LTD. · Tainan City Emerging stock (TPEx) NT$0.5–1B
Shared: Medical device license (Class I), GMP, PIC/S GMP, Human pharmaceutical manufacturing - MEY SEE PHARMACEUTICAL CO., LTD. · Kaohsiung City < NT$20M estimated
Shared: Pharmaceuticals, Human pharmaceutical manufacturing - TA FONG PHARMACEUTICAL CO., LTD. · Changhua County < NT$20M estimated
Shared: Pharmaceuticals, GMP, PIC/S GMP, Human pharmaceutical manufacturing